The estimated Net Worth of John Mc Cune Jr. Rice is at least 1.49 百万$ dollars as of 8 February 2021. John Rice owns over 27,205 units of Meridian Bioscience stock worth over 1,389,950$ and over the last 7 years he sold VIVO stock worth over 0$. In addition, he makes 103,000$ as Independent Director at Meridian Bioscience.
Sign up
John Rice VIVO stock SEC Form 4 insiders trading
John has made over 5 trades of the Meridian Bioscience stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 27,205 units of VIVO stock worth 315,578$ on 8 February 2021.
The largest trade he's ever made was exercising 27,205 units of Meridian Bioscience stock on 8 February 2021 worth over 315,578$. On average, John trades about 2,934 units every 91 days since 2017. As of 8 February 2021 he still owns at least 40,917 units of Meridian Bioscience stock.
You can see the complete history of John Rice stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Rice biography
Dr. John McCune Rice Ph.D. serves as Independent Director of the Company. John M. Rice is a Managing Director leading the Life Sciences practice at CincyTech, a firm that provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions to regional companies, having previously served as Director of Life Sciences since 2014. Dr. Rice is also the founder of Triathlon Medical Venture Partners, a venture capital firm that invests equity capital in early and expansion stage life science companies, having served as Managing Partner from 2003 – 2018. In addition, Dr. Rice has served on the board of directors of several privately-held health care companies. The Board believes that Dr. Rice’s scientific background and years of experience with a number of companies operating in the health care and related industries, as well as extensive experience within the capital markets, is extremely valuable to Meridian.
What is the salary of John Rice?
As the Independent Director of Meridian Bioscience, the total compensation of John Rice at Meridian Bioscience is 103,000$. There are 11 executives at Meridian Bioscience getting paid more, with John P. Kenny having the highest compensation of 1,508,705$.
What's John Rice's mailing address?
John's mailing address filed with the SEC is 3471 RIVER HILLS DRIVE, , CINCINNATI, OH, 45244.
Insiders trading at Meridian Bioscience
Over the last 22 years, insiders at Meridian Bioscience have traded over 8,089,514$ worth of Meridian Bioscience stock and bought 228,244 units worth 3,053,655$ . The most active insiders traders include Richard Eberly、John P. Kenny、John A Kraeutler. On average, Meridian Bioscience executives and independent directors trade stock every 41 days with the average trade being worth of 424,761$. The most recent stock trade was executed by James M. Anderson on 6 January 2023, trading 8,500 units of VIVO stock currently worth 173,230$.
What does Meridian Bioscience do?
Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.
What does Meridian Bioscience's logo look like?
Complete history of John Rice stock trades at Meridian Bioscience
Meridian Bioscience executives and stock owners
Meridian Bioscience executives and other stock owners filed with the SEC include:
-
John P. Kenny,
Pres, CEO & Director -
John Kenny,
Chief Executive Officer, Director -
Lourdes Weltzien,
Executive Vice President - Life Science -
Dr. Lourdes G. Weltzien Ph.D.,
Exec. VP of Life Science Bus. Unit -
Tony Serafini-Lamanna,
Exec. VP of Diagnostics -
Bryan Baldasare,
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Corporate Controller, Treasurer -
David Phillips,
Independent Chairman of the Board -
James Anderson,
Independent Director -
Dwight Ellingwood,
Independent Director -
Felicia Williams,
Independent Director -
Catherine Sazdanoff,
Independent Director -
John Rice,
Independent Director -
John McIlwraith,
Independent Director -
Anthony Bihl,
Independent Director -
Melissa A. Lueke,
Consultant -
Susan D. Rolih,
Consultant -
Melissa J. McCarey,
VP of Global HR -
Charles Wood,
VP of Investor Relations -
Jeff Pinkston,
Director of Corp. Fin. -
Julie Smith,
Sr. VP, Controller & Principal Accounting Officer -
Michael C. Shaughnessy,
EVP, Pres Meridian Global Dx -
Amy Winslow,
EVP, Pres & CEO of Magellan -
Melissa Lueke,
Exec VP, CFO -
Marco G. Calzavara,
Pres & Managing Director, MBE -
Vecheslav A Elagin,
Sr VP, Research & Development -
Eric S. Rasmussen,
EVP, Bus. Development/Strategy -
Kenneth Kozak,
Vice President -
Susan Rolih,
EVP, Reg & Quality Systems -
Lawrence Baldini,
VP, Operations -
Robert J Ready,
Director -
Marviette D. Johnson,
VP, Human Resources -
Todd W Motto,
VP, Sales and Marketing -
Grady Barnes,
VP, Research & Development -
Gregory S Ballish,
VP, Sales and Marketing -
James Buzard,
Director -
Richard Eberly,
Ex. VP, Gen Mgr. Mer. Life Sci -
Gary P Kreider,
Director -
Vivo Family Limited Partner...,
10% owner -
William J Motto,
Chairman, CEO -
Antonio Interno,
Senior Vice President -
John A Kraeutler,
Chairman and CEO -
Tony Serafini Lamanna,
Executive VP-Diagnostics